Each identified molecular subtype is characterized by a panel of genetic alterations; in a simplistic manner, classical, mesenchymal, and proneural GBM subtypes are characterized by modifications in EGFR, NF1, and PDGFRA/IDH1, respectively [1]. Here, IDH1 is linked to glioblastoma.